本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Axsome Therapeutics, Inc.

129.55
+2.491.96%
盤後129.550.00000.00%19:50 EDT
成交量:53.06萬
成交額:6,861.56萬
市值:64.65億
市盈率:-25.58
高:130.63
開:127.28
低:127.17
收:127.06
52周最高:139.13
52周最低:75.56
股本:4,990.15萬
流通股本:4,187.28萬
量比:1.21
換手率:1.27%
股息:- -
股息率:- -
每股收益(TTM):-5.0644
每股收益(LYR):-5.9944
淨資產收益率:-280.68%
總資產收益率:-21.90%
市淨率:88.47
市盈率(LYR):-21.61

資料載入中...

2025/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/20

重要事件披露

Form 8-K - Current report
2025/08/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/04

重要事件披露

Form 8-K - Current report
2025/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities